|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM380483270 |
| 003 |
DE-627 |
| 005 |
20250306224426.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
241120s2025 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2024.110399
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1267.xml
|
| 035 |
|
|
|a (DE-627)NLM380483270
|
| 035 |
|
|
|a (NLM)39561928
|
| 035 |
|
|
|a (PII)S1521-6616(24)00508-4
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Mazzola, Alessandra
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a HLA evolutionary divergence effect on bacterial infection risk in cirrhotic liver transplant candidates
|
| 264 |
|
1 |
|c 2025
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 10.12.2024
|
| 500 |
|
|
|a Date Revised 10.12.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2024. Published by Elsevier Inc.
|
| 520 |
|
|
|a Bacterial infections are common in cirrhosis patients, increasing the risk of decompensation and death. The impact of HLA evolutionary divergence (HED) on infection risk hasn't been studied in humans before. We conducted a retrospective study on cirrhosis patients awaiting liver transplantation (LT) from January 2019 to February 2022, examining class I and II-HED effects on bacterial infections and cirrhosis decompensation. We included 269 cirrhosis patients. Among them, 98 experienced 153 bacterial infections. Multivariable analysis after variable selection revealed that higher class II-HED was linked to fewer bacterial infections (p = 0.034), while class I-HED showed no effect (p = 0.074). Independent risk factors for bacterial infections included invasive procedures (p < 0.001), ICU hospitalization (p < 0.001), recent antibiotic treatment (p = 0.046), rifaximin use (p = 0.043), and cirrhosis decompensation (p = 0.002). Neither class I nor II-HED affected decompensation risk. This pioneering study shows that high class II-HED levels may protect against bacterial infections in cirrhosis patients awaiting LT, suggesting an immunological mechanism at play
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Bacterial infections
|
| 650 |
|
4 |
|a Cirrhosis
|
| 650 |
|
4 |
|a Cirrhosis decompensation
|
| 650 |
|
4 |
|a HLA evolutionary divergence
|
| 650 |
|
4 |
|a Liver transplantation
|
| 650 |
|
7 |
|a HLA Antigens
|2 NLM
|
| 700 |
1 |
|
|a Roger, Clémentine
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lhotte, Romain
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mallet, Maxime
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Thabut, Dominique
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Taupin, Jean-Luc
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Conti, Filomena
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 270(2025) vom: 15. Jan., Seite 110399
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
| 773 |
1 |
8 |
|g volume:270
|g year:2025
|g day:15
|g month:01
|g pages:110399
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2024.110399
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 270
|j 2025
|b 15
|c 01
|h 110399
|